A 120-Minute Saline Infusion Test for the Confirmation of Primary Aldosteronism: A Pilot Study.

IF 3.1 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE American Journal of Hypertension Pub Date : 2024-05-15 DOI:10.1093/ajh/hpae017
Tiran Golani, Jonathan Bleier, Alon Kaplan, Tammy Hod, Yehonatan Sharabi, Avshalom Leibowitz, Ehud Grossman, Gadi Shlomai
{"title":"A 120-Minute Saline Infusion Test for the Confirmation of Primary Aldosteronism: A Pilot Study.","authors":"Tiran Golani, Jonathan Bleier, Alon Kaplan, Tammy Hod, Yehonatan Sharabi, Avshalom Leibowitz, Ehud Grossman, Gadi Shlomai","doi":"10.1093/ajh/hpae017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The saline infusion test (SIT) to confirm primary aldosteronism requires infusing 2 L of normal saline over 240 minutes. Previous studies raised concerns regarding increased blood pressure and worsening hypokalemia during SIT. We aimed to evaluate the diagnostic applicability of a SIT that requires 1 L of saline infusion over 120 minutes.</p><p><strong>Methods: </strong>A cross-sectional study, including all patients in a large medical center who underwent SIT from 1 January 2015 to 30 April 2023. Blood samples were drawn for baseline renin and aldosterone (t = 0) after 2 hours (t = 120 min) and after 4 hours (t = 240 min) of saline infusion. We used ROC analysis to evaluate the sensitivity and specificity of various aldosterone cut-off values at t = 120 to confirm primary aldosteronism.</p><p><strong>Results: </strong>The final analysis included 62 patients. A ROC analysis yielded 97% specificity and 90% sensitivity for a plasma aldosterone concentration (PAC) of 397 pmol/L (14 ng/dL) at t = 120 to confirm primary aldosteronism, and an area under the curve of 0.97 (95% CI [0.93, 1.00], P < 0.001). Almost half (44%) of the patients did not suppress PAC below 397 pmol/L (14 ng/dL) at t = 120. Of them, only one (4%) patient suppressed PAC below 276 pmol/L (10 ng/dL) at t = 240. Mean systolic blood pressure increased from 140.1 ± 21.3 mm Hg at t = 0 to 147.6 ± 14.5 mm Hg at t = 240 (P = 0.011).</p><p><strong>Conclusions: </strong>A PAC of 397 pmol/L (14 ng/dL) at t = 120 has high sensitivity and specificity for primary aldosteronism confirmation.</p>","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":"415-420"},"PeriodicalIF":3.1000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpae017","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The saline infusion test (SIT) to confirm primary aldosteronism requires infusing 2 L of normal saline over 240 minutes. Previous studies raised concerns regarding increased blood pressure and worsening hypokalemia during SIT. We aimed to evaluate the diagnostic applicability of a SIT that requires 1 L of saline infusion over 120 minutes.

Methods: A cross-sectional study, including all patients in a large medical center who underwent SIT from 1 January 2015 to 30 April 2023. Blood samples were drawn for baseline renin and aldosterone (t = 0) after 2 hours (t = 120 min) and after 4 hours (t = 240 min) of saline infusion. We used ROC analysis to evaluate the sensitivity and specificity of various aldosterone cut-off values at t = 120 to confirm primary aldosteronism.

Results: The final analysis included 62 patients. A ROC analysis yielded 97% specificity and 90% sensitivity for a plasma aldosterone concentration (PAC) of 397 pmol/L (14 ng/dL) at t = 120 to confirm primary aldosteronism, and an area under the curve of 0.97 (95% CI [0.93, 1.00], P < 0.001). Almost half (44%) of the patients did not suppress PAC below 397 pmol/L (14 ng/dL) at t = 120. Of them, only one (4%) patient suppressed PAC below 276 pmol/L (10 ng/dL) at t = 240. Mean systolic blood pressure increased from 140.1 ± 21.3 mm Hg at t = 0 to 147.6 ± 14.5 mm Hg at t = 240 (P = 0.011).

Conclusions: A PAC of 397 pmol/L (14 ng/dL) at t = 120 has high sensitivity and specificity for primary aldosteronism confirmation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于确认原发性醛固酮增多症的 120 分钟生理盐水输注试验:试点研究
背景:确认原发性醛固酮增多症的生理盐水输注试验(SIT)需要在 240 分钟内输注两升正常生理盐水。之前的研究提出了对 SIT 期间血压升高和低钾血症恶化的担忧。我们旨在评估需要在 120 分钟内输注一升生理盐水的 SIT 的诊断适用性:横断面研究,包括一家大型医疗中心自 2015 年 1 月 1 日至 2023 年 4 月 30 日期间接受 SIT 的所有患者。在输注生理盐水两小时后(t=120 分钟)和四小时后(t=240 分钟)抽取血样检测基线肾素和醛固酮(t=0)。我们使用 ROC 分析评估了 t=120 时不同醛固酮临界值对确认原发性醛固酮增多症的敏感性和特异性:最终分析包括 62 名患者。ROC分析结果显示,t=120时血浆醛固酮浓度为397 pmol/L (14 ng/dL)时,确诊原发性醛固酮增多症的特异性为97%,灵敏度为90%,曲线下面积为0.97 (95% CI [0.93, 1.00],P < 0.001)。近一半(44%)的患者在 t=120 时未将 PAC 抑制到 397 pmol/L (14 ng/dL)以下。其中,只有一名(4%)患者在 t=240 时将 PAC 控制在 276 pmol/L (10 ng/dL)以下。平均收缩压从 t=0 时的 140.1±21.3 mm/Hg 升至 t=240 时的 147.6±14.5 mm/Hg(p=0.011):结论:t=120时PAC为397 pmol/l(14 ng/dL),对原发性醛固酮增多症的确认具有较高的敏感性和特异性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American Journal of Hypertension
American Journal of Hypertension 医学-外周血管病
CiteScore
6.90
自引率
6.20%
发文量
144
审稿时长
3-8 weeks
期刊介绍: The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.
期刊最新文献
Cardiovascular and Kidney Outcomes of Living Kidney Donors With Preexisting Hypertension: A Systematic Review and Meta-Analysis. Effect of Very Low-Intensity Resistance Exercise on Aortic-Brachial Blood Pressure Disparity in Young Men. State of the Art Review: Thiazide Diuretics Exploit the Endocannabinoid System via NAPE-PLD. Treatment Targets for Blood-Pressure-Lowering in Patients With Diabetes Mellitus. Brachial Systolic Pressure Averages Twice Diastolic: Evidence From Invasive High-Fidelity Pressure Recordings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1